Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Recursion Pharmaceuticals shares were 11% higher, at $3.90, after the company reported fourth-quarter revenue that was higher than last year, and a loss that was narrower than last year's.

Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are surging Wednesday following a robust earnings report released before the bell.

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological ...

(RXRX) on Wednesday reported a loss of $108.1 million in its fourth quarter. The Salt Lake City-based company said it had ...

A new COPILOT function in Excel lets you use AI in a formula. The new skill is now available to Microsoft 365 insiders. Reduces some of the complexity involved in creating formulas. Get more in-depth ...

Microsoft Excel’s new COPILOT function lets users generate, summarize, and analyze data directly in spreadsheet cells using plain-language prompts. (Microsoft Image) Microsoft is building generative ...

Have you ever stared at a tangled web of Excel formulas, wondering if there’s a better way to make sense of it all? For many, Excel’s LAMBDA function feels like a cryptic puzzle—powerful but ...

Have you ever found yourself staring at a sprawling Excel spreadsheet, overwhelmed by rows and columns of data that seem impossible to manage? You’re not alone. Despite its reputation as a workplace ...

Maintaining optimal brain health has become a priority for many individuals in a fast-paced world where mental demands are constantly rising. Neuro Surge is a groundbreaking supplement specifically ...